FOXO1 mitigates the SMAD3/FOXL2C134W Transcriptomic Effect in a Model of Human Adult Granulosa Cell Tumor
C. Secchi, P. Benaglio, F. Mulas, M. Belli, D. Stupack, S. Shimasaki
The paper identifies FOXO1 as a potential therapeutic target that mitigates the transcriptomic effects of FOXL2C134W mutation in adult granulosa cell tumors.
bioRxiv · Dec 15, 2020Cancer Biology